US › Healthcare

First Tracks Biotherapeutics (TRAX)

US · Healthcare · Biotechnology

$46.01-0.32%
Last close · 2026-08-04

Key statistics

Market cap
$1.61B
Forward P/E
0.0
P/B
5.97
Book value
$7.38
EPS (TTM)
$-4.71
52-week high
$49.58
52-week low
$11.30
50-day MA
$24.47
200-day MA
$22.88

Analyst view

with an average price target of $50.75.

Shareholding

Insiders
8.95%
Institutions
52.56%

Largest institutional holders

FundStake
Financial Enhancement Group LLC0.21%
Tema ETFs0.09%
Y-Intercept (Hong Kong) Ltd0.08%
GAMMA Investing LLC0.00%
MASSMUTUAL TRUST CO FSB/ADV0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for First Tracks Biotherapeutics — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.